https://www.selleckchem.com/products/ml324.html
This study was carried out to describe the profile of prescription of antiosteoporotic treatment at discharge after a hip fracture in the Spanish National Hip Fracture Registry. Prescription rates among hospitals ranged from 0 to 94% of patients discharged. The prescription rate was higher among patients with better cognitive and functional baseline status. PURPOSE National hip fracture registries are useful for assessing current care processes. The goals of this study were as follows first, to know the rate of antiosteoporotic prescripti